RockStep’s team is driven by a passion to save lives by helping get drugs and vaccines to market faster.
The team recognized that preclinical drug discovery and in vivo research operations were in a state of data chaos and the problem was increasing rapidly. Until the release of Climb™, academia and industry had no good tools for managing data and operations for in vivo research. A typical research organization used email, share-folders, spreadsheets, binders, and legacy point solutions to manage crucial data and complex lab operations.
Backed by the National Institutes of Health through an SBIR Award (GM112206), RockStep spent several years working with a tier-1 pharmaceutical company, a large public biotech, and the lab of a Nobel Laureate (Dr. Prusiner at UCSF), to design and create a platform that is now widely adopted by world-leading biomedical research and drug discovery organizations.
With vast industry experience, three innovation awards, and a passion to do something important, RockStep’s founders built an elegant, modern, comprehensive, but easy to use, informatics platform for pre and non-clinical research called Climb™.
RockStep has also won awards from Microsoft to conduct co-development projects and to access advanced technologies in the Azure cloud. In spite of the fact that Climb™ runs on all platforms, RockStep has recently be been awarded the coveted Microsoft ISV designation.
RockStep continues to work with frontier scientists and engineers on some of the world’s most advanced technologies to ensure Climb™ leads the industry with a platform for the lab of the now and the lab of the future.
Co-founder of RockStep, Chuck has a degree in Computer Science. Prior to RockStep, Chuck was Director of Computational Sciences at the Jackson Laboratory (JAX), where he led work on intractable computational problems for numerous disease areas including cancer, and diabetes.. Chuck’s work at JAX was funded by the NIH, HHMI, and JAX. Prior to JAX, Chuck was in the Space Astrophysics Group at UC Berkeley where he directed development of software systems for NASA orbiting platforms, worked on the Space Shuttle ground control, and led development of software for imbedded systems, and, algorithms for radio astronomy. Chuck has published articles and papers in peer reviewed journals, and presented at conferences around the world. As CEO, Chuck brings a wealth of business experience, leadership, and management experience to the RockStep team.
Co-founder of RockStep, Julie has a degree in Microbiology. Prior to joining RockStep, she worked at IDEXX labs developing assays for detecting contamination in public water supplies and at the Jet Propulsion Laboratory developing assays for detecting biological surface contamination for deep space missions. For RockStep, Julie works closely with researchers in industry and academia to understand their needs. She uses this knowledge to manage the product roadmap and position Climb within drug discovery research. As President of RockStep, Julie manages all company operations and works closely with the CEO to develop the company’s strategy, financial models, and investment portfolio. Julie has published articles on information systems for research and lectured at industry conferences.
In his former role as Chief Information Officer (CIO) at BiogenIdec and a member of the Executive Committee, Ray Pawlicki was instrumental in restructuring the IT organization, and transforming IT into a strategic asset pivotal to the $8 billion biotech company’s success. Prior to BiogenIdec he worked for eight years at Novartis Pharmaceuticals, A.G., serving as both CIO of the U.S. affiliate and Global CIO of the Switzerland-based, $27 billion enterprise. For RockStep, Ray works closely with the RockStep team providing deep strategic guidance.
Director of Software Engineering
Dave brings 25 years of SaaS technology experience, shepherding growing companies from startup, through growth, and enterprise-level stages.Before RockStep, Dave co-founded Certify, Inc., an enterprise travel & expense management platform (acquired in 2017 by K1 Investment Management) as well as Recruiternet, the first online SaaS recruitment platform (acquired in 2005 by First Advantage Corporation).He is using his deep knowledge of software development, cloud architecture, and technical leadership to help RockStep achieve its goals in the evolving bio-informatics space. Furthermore, his experience in product management, vendor/customer relationship management, audit, as well as M&A, will help RockStep realize success.
Board of Directors/Advisor
Tom Arneman was Founder and President of Ceiba Solutions (managing invention of Lab IT services and application externalization for Pharma RD IT) and Weka Solutions (a Digital Health incubator helping Pharma create new value from internal technology investment). Tom took both companies to exit and is now immersed in helping technology startups succeed and scale. Tom brings significant experience to RockStep in taking companies from startup to scale in the biopharmaceutical industry.
Richard brings years of strategic and tactical experience in finance and operations to RockStep where he is now helping the company focus on accelerating growth and creating enterprise value. He has a diverse background with experience in multiple industries including high tech manufacturing, software, and life sciences. Richard works closely with RockStep’s CEO and BOD on growth strategy, tactical plans, forecasts and budgets with full GAAP based financial reporting. He also has extensive experience raising growth capital, and designing/implementing infrastructure and systems to support rapid scale-up.